Merrimack Pharmaceuticals Inc
MACKDelisted May 10, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001274792
Merrimack Pharmaceuticals Inc was delisted on May 10, 2024; its insiders filed their last Form 4 on Dec 28, 2023; 70 institutions reported holding it in 13F filings for Q1 2024, worth $137.1M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Merrimack Pharmaceuticals Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 41 | 47 | +6 |
| Shares | 8.01M | 7.55M | −457.2K (−5.7%) |
| Value | $30.0M | $86.6M | +$56.5M (+188.1%) |
New holders (12)
Institutions that held Merrimack Pharmaceuticals Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sio Capital Management, LLC | 250,000 | $2.87M | 1.53% |
| OrbiMed Advisors LLC | 73,600 | $843.5K | 0.02% |
| Boothbay Fund Management, LLC | 64,211 | $735.9K | 0.02% |
| Pura Vida Investments, LLC | 64,100 | $734.6K | 0.12% |
| Millennium Management LLC | 16,985 | $195.0K | 0.00% |
| Goldman Sachs Group Inc | 14,142 | $162.1K | 0.00% |
| Freedom Wealth Alliance, LLC | 1,820 | $20.9K | 0.03% |
| JPMorgan Chase & Co | 354 | $4.00K | 0.00% |
| Barclays PLC | 135 | $1.55K | 0.00% |
| Horrell Capital Management, Inc. | 50 | $1.00K | 0.00% |
| Armstrong Advisory Group, Inc | 45 | $516 | 0.00% |
| GWM Advisors LLC | 1,406 | $16 | 0.00% |
Sold out (6)
Institutions that held Merrimack Pharmaceuticals Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 1,100,994 | $4.13M |
| Citadel Advisors LLC | 13,718 | $51.0K |
| Group One Trading, L.P. | 11,930 | $45.0K |
| Simplex Trading, LLC | 8,692 | $32.0K |
| FMR LLC | 1 | $0 |
| City State Bank | 25 | $0 |